IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 253 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,637 | -99.9% | 267,997 | +92.2% | 0.02% | +42.9% |
| Q3 2022 | $1,336,000 | -62.3% | 139,467 | -34.5% | 0.01% | -44.0% |
| Q1 2022 | $3,546,000 | +183.7% | 212,974 | +225.1% | 0.02% | +257.1% |
| Q4 2021 | $1,250,000 | -29.3% | 65,514 | -8.6% | 0.01% | -36.4% |
| Q3 2021 | $1,768,000 | -52.9% | 71,704 | -11.4% | 0.01% | -85.5% |
| Q4 2020 | $3,756,000 | +22.1% | 80,965 | -27.8% | 0.08% | -17.4% |
| Q2 2020 | $3,077,000 | – | 112,098 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,944,201 | $27,999,000 | 13.31% |
| Broadfin Capital, LLC | 4,328,303 | $41,162,000 | 8.50% |
| GREAT POINT PARTNERS LLC | 5,567,348 | $52,945,000 | 5.24% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $20,811,000 | 5.01% |
| Avoro Capital Advisors LLC | 10,530,862 | $100,148,000 | 4.33% |
| Prosight Management, LP | 917,080 | $8,721,000 | 3.82% |
| Perceptive Advisors | 12,235,811 | $116,362,000 | 3.28% |
| Ghost Tree Capital, LLC | 1,150,000 | $10,937,000 | 2.86% |
| QVT Financial LP | 1,021,361 | $9,241,000 | 2.32% |
| Cheyne Capital Management (UK) LLP | 186,500 | $1,774,000 | 1.66% |